Administrative Data Sets and Health Services Research on Hemoglobinopathies. A Review of the Literature

American Journal of Preventive Medicine

Volumn 38, Issue 4 SUPPL., 2010, Pages

  Grosse, Scott D ^a   Boulet, Sheree L ^a   Amendah, Djesika D ^a   Oyeku, Suzette O ^b  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DATA BASE; EMERGENCY CARE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SERVICES RESEARCH; HOSPITAL CARE; HUMAN; OUTPATIENT CARE; PRIVATE HEALTH INSURANCE; SICKLE CELL ANEMIA; THALASSEMIA; UNITED STATES;

ANEMIA, SICKLE CELL; DATABASES, FACTUAL; HEALTH POLICY; HEALTH SERVICES RESEARCH; HEMOGLOBINOPATHIES; HUMANS; MEDICAL RECORD LINKAGE; QUALITATIVE RESEARCH; QUALITY OF HEALTH CARE; THALASSEMIA; UNITED STATES;

EID: 77949434989     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2009.12.015     Document Type: Article

References (39)

1. Waitzman N.J., Scheffler R.M., and Romano P.S. The costs of birth defects: estimates of the value of prevention (1996), University Press of America, Inc, Lanham MD
2. Strouse J.J., Jordan L.C., Lanzkron S., and Casella J.F. The excess burden of stroke in hospitalized adults with sickle cell disease. Am J Hematol 84 (2009) 548-552
3. Riley G.F. Administrative and claims records as sources of healthcare cost data. Med Care 47 7 Suppl 1 (2009) S51-S55
4. Steiner C., and Miller J. Sickle cell disease patients in U.S. hospitals, 2004. HCUP Statistical Brief #21 (2006), Agency for Healthcare Research and Quality, Rockville MD. www.hcup-us.ahrq.gov/reports/statbriefs/sb21.pdf
5. Delea T.E., Hagiwara M., Thomas S.K., et al. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the U.S. Am J Hematol 83 (2008) 263-270
6. Fullerton H.J., Adams R.J., Zhao S., and Johnston S.C. Declining stroke rates in Californian children with sickle cell disease. Blood 104 (2004) 336-339
7. Woods K., Karrison T., Koshy M., Patel A., Friedmann P., and Cassel C. Hospital utilization patterns and costs for adult sickle cell patients in Illinois. Public Health Rep 112 (1997) 44-51
8. Lanzkron S., Haywood Jr. C., Segal J.B., and Dover G.J. Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea. Am J Hematol 81 (2006) 927-932
9. Davis H., Moore Jr. R.M., and Gergen P.J. Cost of hospitalizations associated with sickle cell disease in the U.S. Public Health Rep 112 (1997) 40-43
10. Panepinto J.A., Brousseau D.C., Hillery C.A., and Scott J.P. Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease. Pediatr Blood Cancer 44 (2005) 182-186
11. Okumura M.J., Campbell A.D., Nasr S.Z., and Davis M.M. Inpatient healthcare use among adult survivors of chronic childhood illnesses in the U.S. Arch Pediatr Adolesc Med 160 (2006) 1054-1060
12. Kourtis A.P., Bansil P., Johnson C., Meikle S.F., Posner S.F., and Jamieson D.J. Children with sickle cell disease and human immunodeficiency virus-1 infection: use of inpatient care services in the U.S. Pediatr Infect Dis J 26 (2007) 406-410
13. Ellison A.M., and Bauchner H. Socioeconomic status and length of hospital stay in children with vaso-occlusive crises of sickle cell disease. J Natl Med Assoc 99 (2007) 192-196
14. Chakravarty E.F., Khanna D., and Chung L. Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease. Obstet Gynecol 111 (2008) 927-934
15. Villers M.S., Jamison M.G., De Castro L.M., and James A.H. Morbidity associated with sickle cell disease in pregnancy. Am J Obstet Gynecol 199 (2008) 125.e1-125.e5
16. James A.H., Bushnell C.D., Jamison M.G., and Myers E.R. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 106 (2005) 509-516
17. James A.H., Jamison M.G., Brancazio L.R., and Myers E.R. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 194 (2006) 1311-1315
18. Mayer M.L., Konrad T.R., and Dvorak C.C. Hospital resource utilization among patients with sickle cell disease. J Health Care Poor Underserved 14 (2003) 122-135
19. DeFrances C.J., Lucas C.A., Buie V.C., and Glonsinskiy A. 2006 National Hospital Discharge Survey. National Health Statistics Reports, No. 5 (2008), National Center for Health Statistics, CDC, Hyattsville MD. www.cdc.gov/nchs/data/nhsr/nhsr005.pdf
20. Healthcare Cost and Utilization Project (HCUP). Introduction to the HCUP Nationwide Inpatient Sample (NIS) 2007 (2009), Agency for Healthcare Research and Quality, Rockville MD. www.hcup-us.ahrq.gov/db/nation/nis/NIS_2007_Introduction.pdf
21. Healthcare Cost and Utilization Project (HCUP). Introduction to the HCUP Kids' Inpatient Database (KID) 2006 (2008), Agency for Healthcare Research and Quality, Rockville MD. www.hcup-us.ahrq.gov/db/nation/kid/KID_2006_Introduction.pdf
22. Bilenker J.H., Weller W.E., Shaffer T.J., Dover G.J., and Anderson G.F. The costs of children with sickle cell anemia: preparing for managed care. J Pediatr Hematol Oncol 20 (1998) 528-533
23. Kuhlthau K., Ferris T.G., Beal C.A., Goshen Y., and Perrin J.M. Who cares for Medicaid-enrolled children with chronic conditions?. Pediatrics 108 (2001) 906-912
24. Sox C.M., Cooper W.O., Koepsell T.D., DiGiuseppe D.L., and Christakis D.A. Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease. JAMA 290 (2003) 1057-1061
25. Shankar S.M., Arbogast P.G., Mitchel E., Cooper W.O., Wang W.C., and Griffin M.R. Medical care utilization and mortality in sickle cell disease: a population-based study. Am J Hematol 80 (2005) 262-270
26. Shankar S.M., Arbogast P.G., Mitchel E., Ding H., Wang W.C., and Griffin M.R. Impact of proximity to comprehensive sickle cell center on utilization of healthcare services among children with sickle cell disease. Pediatr Blood Cancer 50 (2008) 66-71
27. Halasa N.B., Shankar S.M., Talbot T.R., et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 44 (2007) 1428-1433
28. Kauf T.L., Coates T.D., Huazhi L., Mody-Patel N., and Hartzema A.G. The cost of health care for children and adults with sickle cell disease. Am J Hematol 84 (2009) 323-327
29. Shatin D., Levin R., Ireys H.T., and Haller V. Healthcare utilization by children with chronic illnesses: a comparison of Medicaid and employer-insured managed care. Pediatrics 102 (1998) E44
30. Raphael J.L., Dietrich C.L., Whitmire D., Mahoney D.H., Mueller B.U., and Giardino A.P. Healthcare utilization and expenditures for low-income children with sickle cell disease. Pediatr Blood Cancer 52 (2009) 263-267
31. Mvundura M., Amendah D., Kavanagh P.L., Sprinz P.G., and Grosse S.D. Healthcare utilization and expenditures for privately and publicly insured children with sickle cell disease in the U.S. Pediatr Blood Cancer 53 (2009) 642-646
32. Amendah D.D., Mvundura M., Kavanagh P.L., Sprinz P.G., and Grosse S.D. Sickle cell disease-related pediatric medical expenditures in the U.S. Am J Prev Med 38 4S (2010) S550-S556
33. Boulet S.L., Yanni E.A., Creary M.S., and Olney R.S. Health status and healthcare use in a national sample of children with sickle cell disease. Am J Prev Med 38 4S (2010) S528-S535
34. Grigorescu V., Kleyn M.J., Korzeniewski S.J., Young W.I., and Whitten-Shurney W. Newborn screening follow-up within the lifespan context: Michigan's experience. Am J Prev Med 38 4S (2010) S522-S527
35. Korzeniewski SJ, Grigorescu V, Copeland G, et al. Methodological innovations in data gathering: newborn screening linkage with live births records, Michigan, 1/2007-3/2008. Matern Child Health J. In press.
36. Vichinsky E.P., MacKlin E.A., Waye J.S., Lorey F., and Olivieri N.F. Changes in the epidemiology of thalassemia in North America: a new minority disease. Pediatrics 116 (2005) e818-e825
37. Yusuf H.R., Atrash H.K., Grosse S.D., Parker C.S., and Grant A.M. Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999-2007. Am J Prev Med 38 4S (2010) S536-S541
38. Severinsen MT, Kristensen SR, Overvad K, Dethlefsen C, Tjønneland A, Johnsen SP. Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol. In press.
39. Bharmal M.F., Weiner M., Sands L.P., Xu H., Craig B.A., and Thomas III J. Impact of patient selection criteria on prevalence estimates and prevalence of diagnosed dementia in a Medicaid population. Alzheimer Dis Assoc Disord 21 (2007) 92-100